In reality, COVID-19 does not represent the terrifying existential threat of 2020. It is now simply part of the ever-circulating family (and I use that term loosely) of viruses that enter and leave our systems at will.

The only major difference being that we all know the name of this one. It is still not widely appreciated. However, that the entire reason for COVID-19’s status as ‘just another virus’ is the work of the life sciences industry (shout out to Professor Sarah Gilbert!).

And it’s worth reiterating that the current status quo of relative COVID calm is not due to Boris Johnson or Matt Hancock or Harry & Meghan, or Bluey for that matter. It is squarely down to the unheralded lab crews of these fair isles.
Indeed, history may never truly recognise pharma as the defacto freedom fighter of the pandemic story, so I’m dropping it in here for posterity.

Navigating threats at light speed will continue to dictate the narrative, with technology, digital, AI and the life sciences taking a leading role. And thus, healthcare professionals – more specifically doctors and nurses – will inevitably embrace ‘the future’, and collaborate with it.

Undoubtedly, from the tumult of industrial action and razzmatazz of an era-defining election, next year, the emergence of a match fit pharma/NHS union has never been more crucial.

Enjoy the mag,

John Pinching
editor

PharmaTimes Media Ltd,
Mansard House, Church Road,
Little Bookham, Surrey, KT23 3JG
Tel: +44 (0)20 7240 6999
www.pharmatimes.com Twitter: @PharmaTimes

EDITORIAL
John Pinching / editor
john.pinching@pharmatimes.com

Iona Everson / group managing editor
iona.everson@pharmatimes.com

Karl Equi / executive director
karl.equi@pharmatimes.com  

SALES & MARKETING
Tara Lovegrove / business director
tara.lovegrove@pharmatimes.com

Luci Sargood / business manager
luci.sargood@pharmatimes.com

SUBSCRIPTIONS/REPRINTS
Digital and paper copies available free to qualifying readers: www.pharmatimes.com/subscribe
Tel: 01372 414 222
subscriptions@pharmatimes.com
Paper subscriptions available at £90.00 UK and £100.00 overseas per annum.

Views expressed by the contributors do not necessarily represent those of the publisher, editor or staff.

Material may not be reproduced in any form without the publisher’s written permission. © Copyright 2023 PharmaTimes Magazine. All rights reserved. PharmaTimes Magazine is published by PharmaTimes Media Ltd, which is registered as a limited company in England; No 09019637.